Form 10-Q · Quarterly report
Idexx Laboratories 10-Q, filed Nov 2, 2026
- Filed
- CIK
- 0000874716
- Accession no.
- 0000874716-26-000135
Summary
Idexx Laboratories reported third-quarter 2026 revenue of $1.214 billion, up 9.9% year over year with 10.0% organic revenue growth, and income from operations of $402.3 million, up from $354.8 million a year earlier. The company said higher fuel prices and potential supply-chain disruption tied to global conflicts, including hostilities in the Middle East, could raise freight and distribution costs.
Key points
- Idexx Laboratories reported third-quarter 2026 revenue of $1.214 billion, up 9.9% from $1.105 billion a year earlier, with organic revenue growth of 10.0%.
- Companion Animal Group revenue rose 10.2% to $1.116 billion, Water rose 8.4% to $58.8 million, and Livestock, Poultry and Dairy rose 2.6% to $34.8 million.
- Income from operations rose to $402.3 million for the quarter from $354.8 million a year earlier, and to $1.190 billion for the nine months from $1.044 billion.
- Idexx said ongoing global conflicts, including hostilities in the Middle East, have raised fuel prices and could further disrupt transportation networks and supply chains, particularly in Asia Pacific and Europe, increasing freight and distribution costs.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Business Overview We develop, manufacture, and distribute products and provide services primarily for the companion animal veterinary, livestock, poultry and dairy, and water testing sectors. We also manufacture and sell human medical point-of-care diagnostic products. Our primary products and services are: •Point-of-care veterinary diagnostic products, comprised of instruments, consumables, and rapid assay test kits; •Veterinary reference laboratory diagnostic and consulting services; •Practice management systems, software and diagnostic imaging systems and services used by veterinarians; …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.